Leading the Way in Life Science Technologies

GEN Exclusives

More »

Companies

More »

Updated: Feb 24 2012

Polyplus-transfection

  • Polyplus-transfection
  • Bioparc
  • Boulevard Sébastien Brant
  • Illkirch, 67400
  • FRANCE

Polyplus-transfection SA is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction and therapeutics.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »